Anemia Studies in CKD: Erythropoiesis via a Novel PHI Daprodustat - Pediatric (ASCEND-P)

Trial Identifier:	214066
Sponsor:	GlaxoSmithKline
Start Date:	September 2023
Primary Completion Date:	October 2024
Study Completion Date:	March 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Japan	Aichi, Japan, 466-8650
Japan	Saitama, Japan, 330-8777
Japan	Tokyo, Japan, 162-8666
South Korea	Yangsan, South Korea, 50612

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.